Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines

Publisher: La Merie Publishing
Pages: 44
Format: PDF and Online
Product Line:
Competitor Analysis
Product Line:
Target Pipeline
Product Code: LMCA0152
Release Date: September of 2015

300.00 €
Free of 21 % VAT (except in Spain and also in the European Union without valid intl. VAT no),
Delivery costs do not apply or are included.
License:
You can also order this product via email or fax , please download the Order Form
Need more information?
Ask a question about this product

Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines

The Competitive Intelligence Report Amyloid beta- and Tau-Targeted Antibodies & Vaccines as of September 2015 provides a competitor analysis in the development pipeline of novel antibodies and vaccines for passive and active immunotherapy of Alzheimer’s disease or progressive supranuclear palsy (PSP) by targeting amyloid-beta (beta-amyloid) or tau. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in research and development of novel antibodies and vaccines for amyloid beta- and tau-targeted passive and active imunotherapy of Alzheimer’s disease. In addition, the report lists company-specific R&D pipelines of amyloid beta- and tau-targeted antibodies & vaccines. Competitor projects are listed in a tabular format providing Information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product category/Therapeutic Area,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:
The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

 

Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines

Table of Contents:

  • Amyloid beta-Targeted Antibodies
  • Amyloid beta-Targeted Vaccines
  • Tau-Targeted Antibodies
  • Tau-Targeted Vaccines
  • Corporate Amyloid beta- and Tau-Targeted Antibodies & Vaccines R&D Portfolios



The above shown price refers to a Single User License. Please contact us for prices of departmental, site or global product licenses.

This Report is NOT a downloadable item but will be delivered via email within 24 h (working days only).

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top